Efficacy and Safety Profile of Remimazolam-alfentanil Combination for ERCP Sedation
Clinical trial NCT04658173 · UNKNOWN
Trial details
- NCT number
- NCT04658173
- Sponsor
- Tianjin Nankai Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-22
- Primary completion
- 2022-10-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.